379 results · 20ms · Sources: EU EUDAMED, US FDA

Kit, Test,Alpha-Fetoprotein For Testicular Cancer

FDA Pre-Market Approval
FDA Class 2 ·ABBOTT ARCHITECT AFP FOR THE ARCHITECT I2000SR ANALYZER

DIMENSION VISTA (R) AFP FLEX(R) REAGENT CARTRIDGE, MODEL K6454, DIMENSION VISTA (R) LOCI 5 CALIBRATOR, MODEL KC600

FDA 510(k)
FDA Class 2 ·Immunology

EMAX 2 PLUS SYSTEM, MODEL EMAX 2 PLUS MOTOR, EMAX 2 CONSOLE>FIRMWARE UPGRADE, EMAX 2 FP FOOT PEDAL

FDA 510(k)
FDA Class 2 ·Neurology

Cytomegalovirus (Cmv) Dna Quantitative Assay

FDA Pre-Market Approval
FDA Class 2 ·COBAS® AMPLIPREP/COBAS® TAQMAN® CMV TEST (CAP/CTM CMV TEST)

Cytomegalovirus (Cmv) Dna Quantitative Assay

FDA Pre-Market Approval
FDA Class 2 ·COBAS® AMPLIPREP/COBAS® TAQMAN® CMV TEST (CAP/CTM CMV TEST)

Cytomegalovirus (Cmv) Dna Quantitative Assay

FDA Pre-Market Approval
FDA Class 2 ·COBAS® AMPLIPREP/COBAS® TAQMAN® CMV TEST (CAP/CTM CMV TEST)

Cytomegalovirus (Cmv) Dna Quantitative Assay

FDA Pre-Market Approval
FDA Class 2 ·COBAS® AMPLIPREP/COBAS® TAQMAN® CMV TEST (CAP/CTM CMV TEST)

Cytomegalovirus (Cmv) Dna Quantitative Assay

FDA Pre-Market Approval
FDA Class 2 ·COBAS® AMPLIPREP/COBAS® TAQMAN® CMV TEST (CAP/CTM CMV TEST)

Cytomegalovirus (Cmv) Dna Quantitative Assay

FDA Pre-Market Approval
FDA Class 2 ·COBAS® AMPLIPREP/COBAS® TAQMAN® CMV TEST (CAP/CTM CMV TEST)

Cap, Cervical

FDA classification
FDA Class 2 ·Cap, Cervical

Kit, Conception-Assist, Home Use

FDA classification
FDA Class 2 ·Kit, Conception-Assist, Home Use

Cap, Device Disinfectant

FDA classification
FDA Class 2 ·Cap, Device Disinfectant

Monitor, Airway Pressure (Includes Gauge And/Or Alarm)

FDA classification
FDA Class 2 ·Monitor, Airway Pressure (Includes Gauge And/Or Alarm)

Valve, Non-Rebreathing

FDA classification
FDA Class 2 ·Valve, Non-Rebreathing

Hemodialysis Catheter Luer End Cap

FDA classification
FDA Class 2 ·Hemodialysis Catheter Luer End Cap

Procalcitonin Assay

FDA classification
FDA Class 2 ·Procalcitonin Assay

In Situ Polymerizing Peripheral Nerve Cap

FDA classification
FDA Class 2 ·In Situ Polymerizing Peripheral Nerve Cap

Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)

FDA classification
FDA Class 2 ·Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)

Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment

FDA classification
FDA Class 2 ·Test, Alpha Fetoprotein L3 Subfraction (Afp-L3%), For Hepatocellular Carcinoma Risk Assessment